8E71 | pdb_00008e71

Staphylococcus aureus ClpP in complex with compound 3471


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.57 Å
  • R-Value Free: 
    0.171 (Depositor), 0.180 (DCC) 
  • R-Value Work: 
    0.155 (Depositor), 0.168 (DCC) 
  • R-Value Observed: 
    0.156 (Depositor) 

Starting Model: experimental
View more details

wwPDB Validation 3D Report Full Report

Validation slider image for 8E71

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Development of a high throughput and site specific, fluorescent polarization assay to screen for activators of Caseinolytic Protease P leads to the discovery of synthetically tractable new activator class

Singh, A.C.Zhao, Y.Griffith, E.C.Tangallapally, R.Jarret, M.W.Lee, R.E.

To be published.

Macromolecule Content 

  • Total Structure Weight: 325.04 kDa 
  • Atom Count: 22,593 
  • Modeled Residue Count: 2,559 
  • Deposited Residue Count: 2,842 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
ATP-dependent Clp protease proteolytic subunit203Staphylococcus aureus subsp. aureus NCTC 8325Mutation(s): 0 
Gene Names: clpPSAOUHSC_00790
EC: 3.4.21.92
UniProt
Find proteins for Q2G036 (Staphylococcus aureus (strain NCTC 8325 / PS 47))
Explore Q2G036 
Go to UniProtKB:  Q2G036
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupQ2G036
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 2 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
USU
(Subject of Investigation/LOI)

Query on USU



Download:Ideal Coordinates CCD File
CA [auth G]
EA [auth I]
GA [auth K]
IA [auth L]
KA [auth M]
CA [auth G],
EA [auth I],
GA [auth K],
IA [auth L],
KA [auth M],
MA [auth N],
P [auth A],
PA [auth S],
R [auth B],
RA [auth T],
T [auth C],
V [auth D],
X [auth E],
Z [auth F]
(5S,6S,9aS)-N-[(4-fluorophenyl)methyl]-6-methyl-8-[(naphthalen-1-yl)methyl]-4,7-dioxohexahydro-2H-pyrazino[1,2-a]pyrimidine-1(6H)-carboxamide
C27 H27 F N4 O3
UJSSMRPTIGCTEH-MHECFPHRSA-N
MPD

Query on MPD



Download:Ideal Coordinates CCD File
AA [auth G]
BA [auth G]
DA [auth I]
FA [auth K]
HA [auth L]
AA [auth G],
BA [auth G],
DA [auth I],
FA [auth K],
HA [auth L],
JA [auth M],
LA [auth N],
NA [auth S],
O [auth A],
OA [auth S],
Q [auth B],
QA [auth T],
S [auth C],
U [auth D],
W [auth E],
Y [auth F]
(4S)-2-METHYL-2,4-PENTANEDIOL
C6 H14 O2
SVTBMSDMJJWYQN-YFKPBYRVSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.57 Å
  • R-Value Free:  0.171 (Depositor), 0.180 (DCC) 
  • R-Value Work:  0.155 (Depositor), 0.168 (DCC) 
  • R-Value Observed: 0.156 (Depositor) 
Space Group: P 1 21 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 94.68α = 90
b = 126.994β = 93.97
c = 145.851γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
HKL-2000data scaling
PHASERphasing
PDB_EXTRACTdata extraction
HKL-2000data reduction

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

& Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
National Institutes of Health/National Institute Of Allergy and Infectious Diseases (NIH/NIAID)United StatesR01 AI110578

Revision History  (Full details and data files)

  • Version 1.0: 2023-07-05
    Type: Initial release
  • Version 1.1: 2023-10-25
    Changes: Data collection, Refinement description